{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:45:29Z","timestamp":1793677529883,"version":"4.5.1"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>COVID-19 pandemic led to an unprecedented collaborative effort among industry, academia, regulatory bodies, and governments with huge financial investments. Scientists and researchers from India also left no stone unturned to find therapeutic and preventive measures against COVID-19. Indian pharmaceutical companies are one of the leading manufacturers of vaccine in the world, are utilizing its capacity to its maximum, and are one among the forerunners in vaccine research against COVID-19 across the globe. In this systematic review, the information regarding contribution of Indian scientists toward COVID-19 research has been gathered from various news articles across Google platform apart from searching PubMed, WHO site, COVID-19 vaccine tracker, CTRI, clinicaltrials.gov, and websites of pharmaceutical companies. The article summarizes and highlights the various therapeutic and vaccine candidates, diagnostic kits, treatment agents, and technology being developed and tested by Indian researcher community against COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijp.ijp_168_21","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T09:02:45Z","timestamp":1619600565000},"page":"63-72","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Indian contribution toward biomedical research and development in COVID-19"],"prefix":"10.4103","volume":"53","author":[{"given":"Hardeep","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusuya","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Prajapat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Thota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phulen","family":"Sarma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. K.","family":"Saifuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bikash","family":"Medhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20240903","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1080\/07391102.2020.1753580","article-title":"In silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)","volume":"39","author":"Sarma","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"R2-11-20240903","doi-asserted-by":"crossref","first-page":"107716","DOI":"10.1016\/j.jmgm.2020.107716","article-title":"Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2","volume":"101","author":"Prajapat","year":"2020","journal-title":"J Mol Graph Model"},{"key":"R3-11-20240903","doi-asserted-by":"crossref","first-page":"e00382","DOI":"10.1128\/mSystems.00382-20","article-title":"In silico structure-based repositioning of approved drugs for spike glycoprotein S2 domain fusion peptide of SARS-CoV-2: Rationale from molecular dynamics and binding free energy calculations","volume":"5","author":"Shekhar","year":"2020","journal-title":"mSystems"},{"key":"R6-11-20240903","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/ijp.IJP_338_20","article-title":"Update on the target structures of SARS-CoV-2: A systematic review","volume":"52","author":"Prajapat","year":"2020","journal-title":"Indian J Pharmacol"},{"key":"R7-11-20240903","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4103\/ijp.IJP_115_20","article-title":"Drug targets for corona virus: A systematic review","volume":"52","author":"Prajapat","year":"2020","journal-title":"Indian J Pharmacol"},{"key":"R10-11-20240903","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/ijmr.IJMR_1029_20","article-title":"Full-genome sequences of the first two SARS-CoV-2 viruses from India","volume":"151","author":"Yadav","year":"2020","journal-title":"Indian J Med Res"},{"key":"R11-11-20240903","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4103\/ijmr.IJMR_671_20","article-title":"Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India","volume":"151","author":"Choudhary","year":"2020","journal-title":"Indian J Med Res"},{"key":"R12-11-20240903","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1016\/j.csbj.2020.11.005","article-title":"In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis","volume":"18","author":"Tiwari","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"key":"R13-11-20240903","first-page":"S1046","article-title":"Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in vitro validation assays","volume":"14","author":"Gupta","year":"2021","journal-title":"Methods"},{"key":"R14-11-20240903","doi-asserted-by":"crossref","first-page":"e05122","DOI":"10.1016\/j.heliyon.2020.e05122","article-title":"Novel hybrid antiviral VTRRT-13V2.1 against SARS-CoV2 main protease: Retro-combinatorial synthesis and molecular dynamics analysis","volume":"6","author":"Tiwari","year":"2020","journal-title":"Heliyon"},{"key":"R15-11-20240903","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ijbiomac.2020.12.223","article-title":"Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus","volume":"171","author":"Tiwari","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"R16-11-20240903","doi-asserted-by":"crossref","first-page":"101497","DOI":"10.1016\/j.tice.2021.101497","article-title":"Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: A systematic review","volume":"70","author":"Kumar","year":"2021","journal-title":"Tissue Cell"},{"key":"R17-11-20240903","doi-asserted-by":"crossref","first-page":"e3001091","DOI":"10.1371\/journal.pbio.3001091","article-title":"Plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research","volume":"19","author":"Rihn","year":"2021","journal-title":"PLoS Biol"},{"key":"R18-11-20240903","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s13337-020-00637-4","article-title":"Selection of animal models for COVID-19 research","volume":"31","author":"Kumar","year":"2020","journal-title":"Virusdisease"},{"key":"R19-11-20240903","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.3390\/molecules25215091","article-title":"Application of humanized zebrafish model in the suppression of SARS-CoV-2 spike protein induced pathology by tri-herbal medicine coronil via cytokine modulation","volume":"25","author":"Balkrishna","year":"2020","journal-title":"Molecules"},{"key":"R20-11-20240903","doi-asserted-by":"crossref","first-page":"579330","DOI":"10.3389\/fphar.2020.579330","article-title":"Tissue distribution of ACE2 protein in syrian golden hamster (Mesocricetus auratus) and its possible implications in SARS-CoV-2 related studies","volume":"11","author":"Suresh","year":"2020","journal-title":"Front Pharmacol"},{"key":"R24-11-20240903","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"R31-11-20240903","doi-asserted-by":"crossref","first-page":"100025","DOI":"10.1074\/jbc.RA120.016284","article-title":"Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment","volume":"296","author":"Malladi","year":"2020","journal-title":"Biol Chem"},{"key":"R38-11-20240903","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1007\/s00417-020-04752-2","article-title":"Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV","volume":"258","author":"Sarma","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R39-11-20240903","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s00417-020-04864-9","article-title":"Letter to the editor: Possible role of topical povidone iodine in case of accidental ocular exposure to SARS-CoV-2","volume":"258","author":"Sarma","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R40-11-20240903","doi-asserted-by":"crossref","first-page":"110539","DOI":"10.1016\/j.mehy.2021.110539","article-title":"Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?","volume":"149","author":"Kaur","year":"2021","journal-title":"Med Hypotheses"},{"key":"R41-11-20240903","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/L21-0001","article-title":"Hydroxychloroquine in nonhospitalized adults with early COVID-19","volume":"174","author":"Bhattacharyya","year":"2021","journal-title":"Ann Intern Med"},{"key":"R42-11-20240903","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1080\/14712598.2020.1798399","article-title":"Itolizumab, an anti-CD6 monoclonal antibody, as a potential treatment for COVID-19 complications","volume":"20","author":"Loganathan","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"R50-11-20240903","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.3389\/fimmu.2020.01061","article-title":"Interferon-\u03b12b treatment for COVID-19","volume":"11","author":"Zhou","year":"2020","journal-title":"Front Immunol"},{"key":"R78-11-20240903","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jmv.25898","article-title":"Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis","volume":"92","author":"Sarma","year":"2020","journal-title":"J Med Virol"},{"key":"R79-11-20240903","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/ijp.IJP_627_20","article-title":"Safety and efficacy of lopinavir\/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis","volume":"52","author":"Bhattacharyya","year":"2020","journal-title":"Indian J Pharmacol"},{"key":"R80-11-20240903","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4103\/ijp.ijp_998_20","article-title":"Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients","volume":"52","author":"Prakash","year":"2020","journal-title":"Indian J Pharmacol"},{"key":"R81-11-20240903","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4103\/ijp.ijp_1146_20","article-title":"Efficacy and safety of steroid therapy in COVID-19: A rapid systematic review and Meta-analysis","volume":"52","author":"Sarma","year":"2020","journal-title":"Indian J Pharmacol"},{"key":"R83-11-20240903","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1007\/s11606-020-06146-w","article-title":"Chloroquine and hydroxychloroquine for the treatment of COVID-19: A systematic review and meta-analysis","volume":"35","author":"Elavarasi","year":"2020","journal-title":"J Gen Intern Med"},{"key":"R84-11-20240903","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/jmv.26408","article-title":"Convalescent plasma is a clutch at straws in COVID-19 management! A systematic review and meta-analysis","volume":"93","author":"Sarkar","year":"2021","journal-title":"J Med Virol"},{"key":"R85-11-20240903","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/jmv.26483","article-title":"Are the steroids a blanket solution for COVID-19? A systematic review and meta-analysis","volume":"93","author":"Sarkar","year":"2021","journal-title":"J Med Virol"},{"key":"R86-11-20240903","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.hrtlng.2020.08.024","article-title":"The association of D-dimers with mortality, intensive care unit admission or acute respiratory distress syndrome in patients hospitalized with coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis","volume":"50","author":"Bansal","year":"2021","journal-title":"Heart Lung"},{"key":"R88-11-20240903","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s12072-020-10071-9","article-title":"Coronavirus disease (COVID-19) and the liver: A comprehensive systematic review and meta-analysis","volume":"14","author":"Kumar","year":"2020","journal-title":"Hepatol Int"},{"key":"R95-11-20240903","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/ijmr.IJMR_1818_20","article-title":"National sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India: Protocol for community-based surveillance","volume":"151","author":"Kumar","year":"2020","journal-title":"Indian J Med Res"},{"key":"R97-11-20240903","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1016\/S2214-109X(20)30544-1","article-title":"SARS-CoV-2 antibody seroprevalence in India, August \u2013 September, 2020: Findings from the second nationwide household serosurvey","volume":"9","author":"Murhekar","year":"2021","journal-title":"Lancet Glob Health"},{"key":"R98-11-20240903","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/d41586-021-00175-z","article-title":"COVID's mental-health toll: How scientists are tracking a surge in depression","volume":"590","author":"Abbott","year":"2021","journal-title":"Nature"},{"key":"R99-11-20240903","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5958\/2394-2061.2021.00001.X","article-title":"Profile of distress callers and service utilisation of tele-counselling among the population of Assam, India: An exploratory study during COVID-19","volume":"12","author":"Hazarika","year":"2021","journal-title":"Open J Psychiatry Allied Sci"},{"key":"R100-11-20240903","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5958\/2394-2061.2021.00009.4","article-title":"The psychological impact of the COVID-19 pandemic and associated risk factors during the initial stage among the general population in India","volume":"12","author":"Hazarika","year":"2021","journal-title":"Open J Psychiatry Allied Sci"},{"key":"R101-11-20240903","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.dsx.2020.05.041","article-title":"COVID-19 pandemic and challenges for socio-economic issues, healthcare and National Health Programs in India","volume":"14","author":"Gopalan","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"R102-11-20240903","doi-asserted-by":"crossref","first-page":"102227","DOI":"10.1016\/j.ajp.2020.102227","article-title":"COVID-19 and domestic violence against women","volume":"53","author":"Vora","year":"2020","journal-title":"Asian J Psychiatr"},{"key":"R103-11-20240903","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.4103\/ijph.IJPH_524_20","article-title":"Economics of COVID-19: Challenges and the way forward for health policy during and after the pandemic","volume":"64","author":"Prinja","year":"2020","journal-title":"Indian J Public Health"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_168_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:26:44Z","timestamp":1787844404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_168_21"}},"subtitle":["A systematic review"],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_168_21","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}